These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
787 related items for PubMed ID: 19694765
1. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility. Liaw SJ, Wu HC, Hsueh PR. Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765 [Abstract] [Full Text] [Related]
2. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil. Souza LK, Souza Junior AH, Costa CR, Faganello J, Vainstein MH, Chagas AL, Souza AC, Silva MR. Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261 [Abstract] [Full Text] [Related]
3. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark. Hagen F, Hare Jensen R, Meis JF, Arendrup MC. Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834 [Abstract] [Full Text] [Related]
8. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India. Chowdhary A, Randhawa HS, Sundar G, Kathuria S, Prakash A, Khan Z, Sun S, Xu J. J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452 [Abstract] [Full Text] [Related]
9. In vitro mating of Colombian isolates of the Cryptococcus neoformans species complex. Escandón P, Ngamskulrungroj P, Meyer W, Castañeda E. Biomedica; 2007 Jun; 27(2):308-14. PubMed ID: 17713641 [Abstract] [Full Text] [Related]
11. Current scenario of cryptococcosis and antifungal susceptibility pattern in India: a cause for reappraisal. Capoor MR, Mandal P, Deb M, Aggarwal P, Banerjee U. Mycoses; 2008 May; 51(3):258-65. PubMed ID: 18399907 [Abstract] [Full Text] [Related]
12. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas. Andrade-Silva L, Ferreira-Paim K, Silva-Vergara ML, Pedrosa AL. Fungal Biol; 2010 May; 114(5-6):438-45. PubMed ID: 20943154 [Abstract] [Full Text] [Related]
13. Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients. Bertout S, Drakulovski P, Kouanfack C, Krasteva D, Ngouana T, Dunyach-Rémy C, Dongtsa J, Aghokeng A, Delaporte E, Koulla-Shiro S, Reynes J, Mallié M. Clin Microbiol Infect; 2013 Aug; 19(8):763-9. PubMed ID: 23033854 [Abstract] [Full Text] [Related]
14. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII. Aminnejad M, Diaz M, Arabatzis M, Castañeda E, Lazera M, Velegraki A, Marriott D, Sorrell TC, Meyer W. Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254 [Abstract] [Full Text] [Related]
15. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, Yan JJ, Yu KW, Wu JJ, Ko WC, Yang YC, Liu YC, Teng LJ, Liu CY, Luh KT. Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726 [Abstract] [Full Text] [Related]